Federal Register Notice: FDA’s Cellular, Tissue and Gene Therapies Advisory Committee will meet 2/9, from 8 a.m. to about 5:30 p.m. and on 2/10, from 8 a.m. to about 1 p.m. at the Gaithersburg Hilton, 620 Perry Pkwy., Gaithersburg, MD. On 2/9, the committee will conduct a scientific discussion of potency measurements for cellular and gene transfer products. On 2/10, the committee will (1) Discuss the National Toxicology Program on Retroviral Mutagenesis and (2) receive a brief update on the recent review of the research program of the Office of Cellular, Tissue and Gene Therapies, FDA. Procedure: Contact Gail Dapolito or Rosanna L. Harvey, (301) 827-0314. To view this notice, click here.